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Histone acetylation plays a central role in establishing an active chromatin environment for 
transcriptional regulation. The balance between histone acetylation and deacetylation is 
maintained in cells by histone lysine acetyltransferases (KATs) and histone deacetylases 
(HDACs). Imbalance between KATs and HDACs leads to altered acetylation states of genes 
which are associated with tainted state of cells resulting in cancer. HDAC inhibitors have 
been successfully tested as useful tool for cancer prevention and therapy. However such 
inhibitors often results in unintentional gene activation and the development of drug 
resistance. To ensure complete balance and control of histone acetylation in a specific manner 
the function of KATs in cancer requires thorough scrutiny.  
GCN5, was the first KAT to be related with transcription, and is a crucial component of a 
transcriptional regulatory complex. GCN5 has been implicated in vast range of cellular 
functions from cell proliferation and differentiation to DNA damage and regulation of cell 
cycle.  However with such conspicuous attributes in cell functions its role in cancer has been 
meagerly investigated and its involvement in cancer growth is still vague. 
Our study revealed that expression of GCN5 is up-regulated in human hepatocellular 
carcinoma (HCC) tissues and cell lines. Studies in GCN5 knockdown stable cell lines 
elucidated that GCN5 knockdown can inhibitcell proliferation, G1/S phase transition in cell 
cycle and colony formation. GCN5 knockdown attenuated cell migration as demonstrated by 
wound healing assay. Besides that GCN5 regulated several cell cycle related and onco-
proteins such as SRC-3, cyclinD1 and β-catenin. Our data showed that GCN5 can 
transcriptionally regulate SRC-3 expression in HCC cell lines through Akt pathway. GCN5 
can also regulate SRC-3 2k promoter in a dose dependent manner and can combine with 
SRC-3 and E2F1 to enhance SRC-3 promoter activity. The tumor xenograft experiments in 
nude mice divulged that GCN5 knockdown cells produced significantly smaller tumors as 
compared to HepG2 control cells. These results indicate an oncogenic role of GCN5 in HCC 
and require further investigation into the mechanisms and pathways leading to tumor 
development. Moreover GCN5 inhibitors can be tested as potential tool for cancer therapy 
and prognosis. 































































Virchow and Bütschli were among the first scientists who recognized the 
structures now described as chromosomes. The term was coined by von Waldeyer-Hartz, 
referring to the term chromatin, which was introduced by Walther Flemming 
[1]
. Although 
chromosome is present in both prokaryotes and eukaryotes, however prokaryotic 
chromosome differs from eukaryotes in being less sequence based structured and circular 
with a single strand and organized in a structure called nucleoid whereas in eukaryotic cells 
the chromosome exists within nuclei such as those found in plants, yeast, and animals
[2]
. 
Since our focus is on the eukaryotes so details of eukaryotic chromosome will be discussed 
only. Eukaryotes possess multiple large linear chromosomes contained in the cell's nucleus. 
Each chromosome has one centromere, with one or two arms projecting from the centromere, 
although, under most circumstances, these arms are not clearly visible. In addition, most 
eukaryotes have a small circular mitochondrial genome, and some eukaryotes may have 
additional small circular or linear cytoplasmic chromosomes. In the nuclear chromosomes 
of eukaryotes, the uncondensed DNA exists in a semi-ordered structure, where it is wrapped 
around histones (structural proteins), forming a composite material called chromatin. 
1.1.1. Structure of Chromosome: 
In all eukaryotic cells resides a nucleus which contains super coiled genomic DNA, 
constrained, called chromosome. The formation of chromosome takes place with the help of 
structural proteins called histone and compacted by histone and non histone proteins in a 
dynamic polymer which is accompanied with different transcription factors at the time of 
transcription and several other macro molecules. This composition of DNA with 
macromolecules and other proteins associated with it is called chromatin. The structure of 
chromatin is dynamic and varies significantly during different stages of cell cycle. Chromatin 
on its further packaging along with other associated molecules is called nucleosome. In each 
nucleosome, roughly two super helical turns of DNA wrap around an octamer of core histone 
















Chapter 1 Introduction 
2 
 
1.1.1 The Histone Code: 
Nucleosome is the basic repeating unit of chromatin and responsible for its organization. 
Histones are small basic proteins consisting of a globular domain and a more flexible and 
charged NH2-terminus (histone “tail”) that protrudes from the nucleosome. Such intricate 
structure suggests that chromatin structure plays a vital regulatory role and a converging 
point for multiple signaling pathways. 
1.1.2 The Human Chromosome: 
The human genome comprises of 46 chromosomes which is comprised of 22 pairs called 
autosomes and a pair of sex chromosomes having XX chromosome in females and XY 
chromosome in males. Certain genetic traits are linked to a person's sex and are passed on 
through the sex chromosomes. The autosomes contain the rest of the genetic hereditary 
information. All act in the same way during cell division 
[4]
. Hence it would not be wrong to 
say that human chromosomes play a major role in transfer of genetic information from 
parents to offspring and thus is the basis of hereditary. Moreover aberration in human 
chromosomes has been linked with several syndromes and diseases including cancer. Thus 
post translational modifications and mutation including physical damage to chromosomes can 
be leading cause in disease prevalence in Humans.  
1.2 EPIGENETICS: 
Genomic DNA is the physiological template of all eukaryotic genetic information and 
ultimate template of heredity. However DNA transcription is frequently modified by diverse 
array of posttranslational modifications that particularly impinge on histone amino termini, 
thereby regulating access to the underlying DNA. Specific histone modifications can generate 
synergistic or antagonistic interaction affinities for chromatin-associated proteins governing 
the transition between transcriptionally active or silent chromatin states. This epigenetic 
marking system represents a fundamental regulatory mechanism that impact majority, if not 




1.2.1 Epigenetic Modifications:  
Epigenetic modifications can play a vital role in cells from transcriptional regulation to 
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posttranslational modifications of proteins 
[7, 8]
. Covalent modifications of histones can 
regulate all DNA-dependent processes. In the past decades, it has become conspicuous that 
histone modifications are key players in regulation the states and dynamic of chromatin as 
well as in gene expression. Therefore, the enzymatic machineries that set many sites and 
types of histone modifications are vital regulators and provide a wealth of variable 
combinations which in turn provides huge regulatory potential for remodeling chromatin 
states, that facilitate or inhibit gene transcription, DNA replication, repair or recombination, 




1.2.2 Types Of  Modifications: 
Histones contain a globular domain that promotes histone–histone interactions within the 
nucleosome and also provides a binding surface for DNA. In addition, they contain tail 
domains that protrude out of the nucleosome, where they influence histone–histone 
interactions, interactions between histones and DNA, and between histones and other 
proteins. Although both the globular domains and the tail domains can be modified, the 
histone tails are particularly rich in modifications, including methylation, acetylation, 
phosphorylation, ubiquitination and sumoylation 
[10]
. Here lysine acetylation has been 
described in detail. 
1.2.3 Lysine Acetylation: 
Lysine acetylation is a reaction in which an acetyl group from the acetyl coenzyme A 
(acetylCoA) cofactor is transferred to the e-amino nitrogen of lysine residues. This reaction is 
catalyzed by histone acetyltransferases (HATs), whereas the reverse reaction is performed by 
histone deacetylases (HDACs).Vincent Allfrey proposed more than 3 decades ago, that 
histone acetylation was associated with transcriptional activation in eukaryotic cells 
[7, 11]
 
Acetylation at specific lysine residues on particular histones can aid the binding of regulatory 
factors involved in the transcription process at specific steps. Both individual nucleosomes 
and higher-order chromatin folding can block access of RNA polymerase and other factors to 
gene promoters. Acetylation affects chromatin folding as the addition of the acetyl group 
neutralizes the positive charge of the lysine, weakening bonds between histones and the 
negatively charged DNA backbone, as well as the bonds between neighboring nucleosomes, 
allowing for more relaxed chromatin structures leading to gene transcription 
[12]
. Besides that 
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complexes and contribute to their targeting to a specific region. These finding suggest that 
histone acetylation can result in increased transcriptional activity in vivo. It has been found 
that bromo domains of histone acetyl transferase act as acetyl-lysine recognition modules, 
directing enzymes that contain them to particular chromosomal sites.
[13, 14]
 Besides 
transcription, new roles for histone acetylation have been uncovered which includes 
nucleosome assembly, chromatin folding, heterochromatic silencing 
[15]




























Figure 1. Mechanisms of action of acetylation. (a) KATs target both tails and globular domains of all four 
histone proteins. (b) KATs acetylate non-histone proteins including transcription factors (TFs) as well as 
metabolic enzymes and other nuclear and cytoplasmic proteins. (c) Bromodomain-containing proteins bind to 
acetyl-lysines on histone tails and on non-histone proteins.  




1.2.4 HATs and KATs 
Although originally termed histone acetyltransferases (HATs), due to their actions toward 
abundant histone substrates, lysine acetyltransferases (KATs) are located both in the nucleus 
and in the cytoplasm, and they have many non-histone substrates as well. The first HAT 
catalytic proteins were isolated and cloned in the 1990s 
[10, 19, 20]
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that a transcriptional coactivator protein, GCN5, is a nuclear HAT 
[21]
 led to a surge in HAT-
related research and the identification of numerous enzymes and their substrates. HATs can 
be grouped on the basis of their catalytic domains into 3 families: GCN5 N-acetyltransferases 
or GNATs (including GCN5, PCAF, Hat1, and others); MYST HATs (named for the 
founding members of this family: MOZ/Morf, Ybf2, Sas2, and Tip60); p300/CBP; SRC 
(steroid receptor co-activator) including (SRC-1, SRC-2, and SRC-3) and an “orphan class” 




1.2.5 Implication Of Kats In Cancer: 
The fact that histone acetyl transferase can regulate gene transcription and associate with 
transcription factors, has led to momentous advances in dissecting the role of HATs in 
cancer. In past few years all the major HATs have been intimately linked with cancer 
progression. In addition to the HAT domain, Lysine acetyl transferase (KATs) possesses 
several domains that facilitate interactions with other proteins, including reader domains for 
acetylation and other modifications. Together these domains allow for specificity and 
diversity in KAT substrates. Substrates of these enzymes as well as their roles in biological 
functions are continuing to be defined. CBP/p300 have already been implicated in cancer 
development and progression 
[22-25]
.  To date all KATs probed have vital functions in cellular 
differentiation and embryo growth 
[26]
. As many cancers fail to differentiate, it is likely to link 
KATs with tumorigenesis. Several KATs with their established and putative role in variety of 
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Table 1: Representative members of the families, with important physiological roles as well as putative links to 
carcinogenesis are shown. 






Role in cancer  Ref 
GNAT

















H4, H2A WD40 Putative role in HCC 







tumors, Skin tumors 




















MOF Lung cancer. 
Tip60 NuA4 H2A, H4 Tumor suppressor, 
putative role in 
oncogenesis. 
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